Insider Transactions in Q1 2024 at Intuitive Surgical Inc (ISRG)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2024
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
609
+15.59%
|
-
|
|
Feb 26
2024
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,536
-11.17%
|
$597,504
$389.77 P/Share
|
|
Feb 26
2024
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,030
+18.05%
|
-
|
|
Feb 26
2024
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
384
-1.7%
|
$149,376
$389.77 P/Share
|
|
Feb 26
2024
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
1,284
+5.37%
|
-
|
|
Feb 16
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
32
-4.32%
|
$12,096
$378.29 P/Share
|
|
Feb 15
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
30
-3.89%
|
$11,460
$382.03 P/Share
|
|
Feb 15
2024
|
Keith R Leonard Director |
SELL
Bona fide gift
|
Direct |
2,547
-71.07%
|
-
|
|
Feb 14
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
30
-3.75%
|
$11,400
$380.09 P/Share
|
|
Feb 13
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
30
-3.61%
|
$11,250
$375.5 P/Share
|
|
Feb 12
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
30
-3.48%
|
$11,580
$386.09 P/Share
|
|
Feb 12
2024
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
481
-61.75%
|
$185,666
$386.09 P/Share
|
|
Feb 10
2024
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
357
-31.43%
|
$138,516
$388.22 P/Share
|
|
Feb 10
2024
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
838
+42.45%
|
-
|
|
Feb 10
2024
|
Gary Loeb General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
129
-6.37%
|
$50,052
$388.22 P/Share
|
|
Feb 10
2024
|
Gary Loeb General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
315
+13.47%
|
-
|
|
Feb 10
2024
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
729
-0.34%
|
$282,852
$388.22 P/Share
|
|
Feb 10
2024
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,437
+0.66%
|
-
|
|
Feb 10
2024
|
Brian Edward Miller EVP & Chief Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
487
-4.74%
|
$188,956
$388.22 P/Share
|
|
Feb 10
2024
|
Brian Edward Miller EVP & Chief Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,317
+11.37%
|
-
|
|
Feb 10
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Payment of exercise price or tax liability
|
Direct |
425
-33.05%
|
$164,900
$388.22 P/Share
|
|
Feb 10
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
BUY
Exercise of conversion of derivative security
|
Direct |
838
+39.45%
|
-
|
|
Feb 10
2024
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,335
-11.07%
|
$517,980
$388.22 P/Share
|
|
Feb 10
2024
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,634
+17.93%
|
-
|
|
Feb 10
2024
|
Jamie Samath CFO and Head of Business Techn |
SELL
Payment of exercise price or tax liability
|
Direct |
401
-5.48%
|
$155,588
$388.22 P/Share
|
|
Feb 10
2024
|
Jamie Samath CFO and Head of Business Techn |
BUY
Exercise of conversion of derivative security
|
Direct |
1,078
+12.85%
|
-
|
|
Feb 10
2024
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
1,085
-4.0%
|
$420,980
$388.22 P/Share
|
|
Feb 10
2024
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
2,873
+9.58%
|
-
|
|
Feb 10
2024
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
222
-7.63%
|
$86,136
$388.22 P/Share
|
|
Feb 10
2024
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
568
+16.33%
|
-
|
|
Feb 10
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
316
-3.8%
|
$122,608
$388.22 P/Share
|
|
Feb 10
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
958
+10.32%
|
-
|
|
Feb 10
2024
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
338
-1.56%
|
$131,144
$388.22 P/Share
|
|
Feb 10
2024
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
1,078
+4.73%
|
-
|
|
Feb 07
2024
|
David J. Rosa President |
SELL
Open market or private sale
|
Direct |
80,710
-7.88%
|
$31,396,190
$389.28 P/Share
|
|
Feb 07
2024
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
140,850
+12.03%
|
$7,465,050
$53.16 P/Share
|
|
Feb 01
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
39
-8.01%
|
$14,742
$378.41 P/Share
|
|
Jan 29
2024
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Indirect |
4,960
-8.31%
|
$1,855,040
$374.41 P/Share
|
|
Jan 29
2024
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Direct |
24,325
-72.07%
|
$9,146,200
$376.06 P/Share
|
|
Jan 29
2024
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,750
+50.0%
|
$1,721,250
$51.02 P/Share
|
|
Jan 26
2024
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,318
-91.26%
|
$1,597,660
$370.15 P/Share
|
|
Jan 26
2024
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,318
+47.71%
|
$777,240
$180.41 P/Share
|
|
Jan 26
2024
|
Amal M Johnson |
SELL
Open market or private sale
|
Direct |
6,696
-36.39%
|
$2,477,520
$370.08 P/Share
|
|
Jan 26
2024
|
Amal M Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
6,696
+26.68%
|
$374,976
$56.97 P/Share
|
|
Jan 26
2024
|
Alan J Levy Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.68%
|
$740,000
$370.2 P/Share
|
|
Jan 26
2024
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+3.45%
|
$244,000
$122.37 P/Share
|